Effectacy of eyaraj fighara to treatment of mild and moderate constipation in Adults

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200205046385N1

Enrollment

Registered

2020-02-17

Start date

2020-02-20

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation. Constipation

Interventions

Intervention 1: Intervention group:Eyaraj fighara herbal capsules Half an hour before each meal

oral use also treated with metoclopramide 10 mg. Dosage: Half an hour before each meal as a pill. Intervention 2: Control group: This group is Placebo herbal capsules Half an hour before each meal

oral use also treated with metoclopramide 10 mg. Dosage: Half an hour before each meal as a pill.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age more than 18 years have chronic functional constipation Moderate and mild based on ROM III criteria Participation in the study

Exclusion criteria

Exclusion criteria: Lack of mobility and activity addiction Known metabolic disorder (diabetes) Drug use that interferes Nervous drug use No medication as planned Get constipation treatment over 2 weeks ago Symptoms of acute gastroenteritis such as nausea, vomiting, and diarrhea during the study

Design outcomes

Primary

Measure	Time frame
Bowel habit. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Feeling repelled. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Stool consistency. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Feeling pain. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Sensation of incomplete evacuation during defecation. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Straining during bowel movements. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Need to be manipulated to facilitate. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.	—

Measure

Time frame

Bowel habit. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Feeling repelled. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Stool consistency. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Feeling pain. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Sensation of incomplete evacuation during defecation. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Straining during bowel movements. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.;Need to be manipulated to facilitate. Timepoint: Before medication, one week after medication, end of study. Method of measurement: Questionnaire ROM III.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Alizadeh

Islamic Azad University

s13690330@yahoo.com+98 25 3778 0001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026